Compare Enveric Biosciences Inc (ENVB) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Ulta Beauty Inc — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while Ulta Beauty Inc trades at $478.61 (market cap $20.04B). The key difference: Ulta Beauty Inc is far larger — about 3766.9× Enveric Biosciences Inc's market cap, and Ulta Beauty Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | ULTA | |
|---|---|---|
Market Cap | $5.32M | $20.04B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $706.82 |
52-Week Low | $1.28 | $450.75 |
Enterprise Value | $408.82K | $22.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
ULTA Beauty trades at $478.30, up 1.96% today, with a neutral technical signal and strong fundamentals including a 47.45% ROE and 9.36% net margin. Recent earnings beat expectations in Q1 2026, but net cash flow turned negative in 2025. The stock is supported by a loyal customer base and international expansion initiatives, including a new CTO appointment to bolster digital capabilities.
The outlook is positive with a consensus price target of $623.73, implying 30% upside, though risks include competitive pressures and fluctuating cash flows. Analyst sentiment is bullish with 56.5% buy ratings, but investors should monitor margin sustainability and macroeconomic impacts on consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
